nodes	percent_of_prediction	percent_of_DWPC	metapath
Halobetasol Propionate—NR3C1—hematologic cancer	0.143	1	CbGaD
Halobetasol Propionate—Dexamethasone—hematologic cancer	0.121	0.336	CrCtD
Halobetasol Propionate—Betamethasone—hematologic cancer	0.121	0.336	CrCtD
Halobetasol Propionate—Triamcinolone—hematologic cancer	0.118	0.328	CrCtD
Halobetasol Propionate—SERPINA6—Triamcinolone—hematologic cancer	0.0512	0.269	CbGbCtD
Halobetasol Propionate—SERPINA6—Prednisolone—hematologic cancer	0.0433	0.228	CbGbCtD
Halobetasol Propionate—NR3C1—Triamcinolone—hematologic cancer	0.0239	0.126	CbGbCtD
Halobetasol Propionate—NR3C1—Betamethasone—hematologic cancer	0.0205	0.108	CbGbCtD
Halobetasol Propionate—NR3C1—Prednisolone—hematologic cancer	0.0202	0.106	CbGbCtD
Halobetasol Propionate—NR3C1—Prednisone—hematologic cancer	0.0191	0.101	CbGbCtD
Halobetasol Propionate—NR3C1—Dexamethasone—hematologic cancer	0.0119	0.0627	CbGbCtD
Halobetasol Propionate—Fluticasone furoate—Dexamethasone—hematologic cancer	0.00361	0.0127	CrCrCtD
Halobetasol Propionate—Fluticasone furoate—Betamethasone—hematologic cancer	0.00361	0.0127	CrCrCtD
Halobetasol Propionate—Fluticasone furoate—Triamcinolone—hematologic cancer	0.00352	0.0124	CrCrCtD
Halobetasol Propionate—Flumethasone Pivalate—Dexamethasone—hematologic cancer	0.00324	0.0114	CrCrCtD
Halobetasol Propionate—Flumethasone Pivalate—Betamethasone—hematologic cancer	0.00324	0.0114	CrCrCtD
Halobetasol Propionate—Flumethasone Pivalate—Triamcinolone—hematologic cancer	0.00317	0.0111	CrCrCtD
Halobetasol Propionate—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.00314	0.011	CrCrCtD
Halobetasol Propionate—Fluticasone Propionate—Betamethasone—hematologic cancer	0.00314	0.011	CrCrCtD
Halobetasol Propionate—Difluprednate—Betamethasone—hematologic cancer	0.00314	0.011	CrCrCtD
Halobetasol Propionate—Difluprednate—Dexamethasone—hematologic cancer	0.00314	0.011	CrCrCtD
Halobetasol Propionate—Difluprednate—Triamcinolone—hematologic cancer	0.00306	0.0108	CrCrCtD
Halobetasol Propionate—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.00306	0.0108	CrCrCtD
Halobetasol Propionate—Clocortolone—Betamethasone—hematologic cancer	0.00295	0.0104	CrCrCtD
Halobetasol Propionate—Beclomethasone—Betamethasone—hematologic cancer	0.00295	0.0104	CrCrCtD
Halobetasol Propionate—Clocortolone—Dexamethasone—hematologic cancer	0.00295	0.0104	CrCrCtD
Halobetasol Propionate—Prednicarbate—Dexamethasone—hematologic cancer	0.00295	0.0104	CrCrCtD
Halobetasol Propionate—Prednicarbate—Betamethasone—hematologic cancer	0.00295	0.0104	CrCrCtD
Halobetasol Propionate—Fluocinonide—Betamethasone—hematologic cancer	0.00295	0.0104	CrCrCtD
Halobetasol Propionate—Fluocinonide—Dexamethasone—hematologic cancer	0.00295	0.0104	CrCrCtD
Halobetasol Propionate—Beclomethasone—Dexamethasone—hematologic cancer	0.00295	0.0104	CrCrCtD
Halobetasol Propionate—Fluocinonide—Triamcinolone—hematologic cancer	0.00288	0.0101	CrCrCtD
Halobetasol Propionate—Beclomethasone—Triamcinolone—hematologic cancer	0.00288	0.0101	CrCrCtD
Halobetasol Propionate—Clocortolone—Triamcinolone—hematologic cancer	0.00288	0.0101	CrCrCtD
Halobetasol Propionate—Prednicarbate—Triamcinolone—hematologic cancer	0.00288	0.0101	CrCrCtD
Halobetasol Propionate—Fluocortolone—Dexamethasone—hematologic cancer	0.00286	0.0101	CrCrCtD
Halobetasol Propionate—Fluocortolone—Betamethasone—hematologic cancer	0.00286	0.0101	CrCrCtD
Halobetasol Propionate—Fluocortolone—Triamcinolone—hematologic cancer	0.0028	0.00985	CrCrCtD
Halobetasol Propionate—Alclometasone—Betamethasone—hematologic cancer	0.00278	0.0098	CrCrCtD
Halobetasol Propionate—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	0.00278	0.0098	CrCrCtD
Halobetasol Propionate—Fluocinolone Acetonide—Betamethasone—hematologic cancer	0.00278	0.0098	CrCrCtD
Halobetasol Propionate—Alclometasone—Dexamethasone—hematologic cancer	0.00278	0.0098	CrCrCtD
Halobetasol Propionate—Prednicarbate—Prednisone—hematologic cancer	0.00273	0.00963	CrCrCtD
Halobetasol Propionate—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	0.00272	0.00958	CrCrCtD
Halobetasol Propionate—Alclometasone—Triamcinolone—hematologic cancer	0.00272	0.00958	CrCrCtD
Halobetasol Propionate—Amcinonide—Betamethasone—hematologic cancer	0.00271	0.00954	CrCrCtD
Halobetasol Propionate—Amcinonide—Dexamethasone—hematologic cancer	0.00271	0.00954	CrCrCtD
Halobetasol Propionate—Beclomethasone—Prednisolone—hematologic cancer	0.00267	0.0094	CrCrCtD
Halobetasol Propionate—Clocortolone—Prednisolone—hematologic cancer	0.00267	0.0094	CrCrCtD
Halobetasol Propionate—Prednicarbate—Prednisolone—hematologic cancer	0.00267	0.0094	CrCrCtD
Halobetasol Propionate—Fluocortolone—Prednisone—hematologic cancer	0.00266	0.00935	CrCrCtD
Halobetasol Propionate—Amcinonide—Triamcinolone—hematologic cancer	0.00265	0.00932	CrCrCtD
Halobetasol Propionate—Clobetasol propionate—Dexamethasone—hematologic cancer	0.00264	0.00929	CrCrCtD
Halobetasol Propionate—Clobetasol propionate—Betamethasone—hematologic cancer	0.00264	0.00929	CrCrCtD
Halobetasol Propionate—Flunisolide—Betamethasone—hematologic cancer	0.00264	0.00929	CrCrCtD
Halobetasol Propionate—Flunisolide—Dexamethasone—hematologic cancer	0.00264	0.00929	CrCrCtD
Halobetasol Propionate—Diflorasone—Dexamethasone—hematologic cancer	0.00264	0.00929	CrCrCtD
Halobetasol Propionate—Diflorasone—Betamethasone—hematologic cancer	0.00264	0.00929	CrCrCtD
Halobetasol Propionate—Fluocortolone—Prednisolone—hematologic cancer	0.00259	0.00913	CrCrCtD
Halobetasol Propionate—Alclometasone—Prednisone—hematologic cancer	0.00258	0.00909	CrCrCtD
Halobetasol Propionate—Diflorasone—Triamcinolone—hematologic cancer	0.00258	0.00908	CrCrCtD
Halobetasol Propionate—Flunisolide—Triamcinolone—hematologic cancer	0.00258	0.00908	CrCrCtD
Halobetasol Propionate—Clobetasol propionate—Triamcinolone—hematologic cancer	0.00258	0.00908	CrCrCtD
Halobetasol Propionate—Paramethasone—Dexamethasone—hematologic cancer	0.00257	0.00906	CrCrCtD
Halobetasol Propionate—Paramethasone—Betamethasone—hematologic cancer	0.00257	0.00906	CrCrCtD
Halobetasol Propionate—Alclometasone—Prednisolone—hematologic cancer	0.00252	0.00887	CrCrCtD
Halobetasol Propionate—Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.00252	0.00887	CrCrCtD
Halobetasol Propionate—Paramethasone—Triamcinolone—hematologic cancer	0.00251	0.00885	CrCrCtD
Halobetasol Propionate—Amcinonide—Prednisone—hematologic cancer	0.00251	0.00885	CrCrCtD
Halobetasol Propionate—Desoximetasone—Betamethasone—hematologic cancer	0.00251	0.00884	CrCrCtD
Halobetasol Propionate—Desoximetasone—Dexamethasone—hematologic cancer	0.00251	0.00884	CrCrCtD
Halobetasol Propionate—Desoximetasone—Triamcinolone—hematologic cancer	0.00245	0.00864	CrCrCtD
Halobetasol Propionate—Amcinonide—Prednisolone—hematologic cancer	0.00245	0.00864	CrCrCtD
Halobetasol Propionate—Triamcinolone—Dexamethasone—hematologic cancer	0.00245	0.00863	CrCrCtD
Halobetasol Propionate—Triamcinolone—Betamethasone—hematologic cancer	0.00245	0.00863	CrCrCtD
Halobetasol Propionate—Mometasone—Betamethasone—hematologic cancer	0.00245	0.00863	CrCrCtD
Halobetasol Propionate—Mometasone—Dexamethasone—hematologic cancer	0.00245	0.00863	CrCrCtD
Halobetasol Propionate—Fluorometholone—Dexamethasone—hematologic cancer	0.00245	0.00863	CrCrCtD
Halobetasol Propionate—Fluorometholone—Betamethasone—hematologic cancer	0.00245	0.00863	CrCrCtD
Halobetasol Propionate—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.00245	0.00863	CrCrCtD
Halobetasol Propionate—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.00245	0.00863	CrCrCtD
Halobetasol Propionate—Diflorasone—Prednisone—hematologic cancer	0.00245	0.00862	CrCrCtD
Halobetasol Propionate—Flunisolide—Prednisone—hematologic cancer	0.00245	0.00862	CrCrCtD
Halobetasol Propionate—Clobetasol propionate—Prednisone—hematologic cancer	0.00245	0.00862	CrCrCtD
Halobetasol Propionate—Rimexolone—Betamethasone—hematologic cancer	0.0024	0.00843	CrCrCtD
Halobetasol Propionate—Betamethasone—Dexamethasone—hematologic cancer	0.0024	0.00843	CrCrCtD
Halobetasol Propionate—Dexamethasone—Betamethasone—hematologic cancer	0.0024	0.00843	CrCrCtD
Halobetasol Propionate—Rimexolone—Dexamethasone—hematologic cancer	0.0024	0.00843	CrCrCtD
Halobetasol Propionate—Mometasone—Triamcinolone—hematologic cancer	0.0024	0.00843	CrCrCtD
Halobetasol Propionate—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.0024	0.00843	CrCrCtD
Halobetasol Propionate—Fluorometholone—Triamcinolone—hematologic cancer	0.0024	0.00843	CrCrCtD
Halobetasol Propionate—Clobetasol propionate—Prednisolone—hematologic cancer	0.00239	0.00841	CrCrCtD
Halobetasol Propionate—Flunisolide—Prednisolone—hematologic cancer	0.00239	0.00841	CrCrCtD
Halobetasol Propionate—Diflorasone—Prednisolone—hematologic cancer	0.00239	0.00841	CrCrCtD
Halobetasol Propionate—Paramethasone—Prednisone—hematologic cancer	0.00239	0.0084	CrCrCtD
Halobetasol Propionate—Dexamethasone—Triamcinolone—hematologic cancer	0.00234	0.00824	CrCrCtD
Halobetasol Propionate—Betamethasone—Triamcinolone—hematologic cancer	0.00234	0.00824	CrCrCtD
Halobetasol Propionate—Rimexolone—Triamcinolone—hematologic cancer	0.00234	0.00824	CrCrCtD
Halobetasol Propionate—Paramethasone—Prednisolone—hematologic cancer	0.00233	0.0082	CrCrCtD
Halobetasol Propionate—Desoximetasone—Prednisone—hematologic cancer	0.00233	0.0082	CrCrCtD
Halobetasol Propionate—Methylprednisolone—Dexamethasone—hematologic cancer	0.00229	0.00807	CrCrCtD
Halobetasol Propionate—Methylprednisolone—Betamethasone—hematologic cancer	0.00229	0.00807	CrCrCtD
Halobetasol Propionate—Mometasone—Prednisone—hematologic cancer	0.00227	0.008	CrCrCtD
Halobetasol Propionate—Triamcinolone—Prednisone—hematologic cancer	0.00227	0.008	CrCrCtD
Halobetasol Propionate—Fluorometholone—Prednisone—hematologic cancer	0.00227	0.008	CrCrCtD
Halobetasol Propionate—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00227	0.008	CrCrCtD
Halobetasol Propionate—Desoximetasone—Prednisolone—hematologic cancer	0.00227	0.008	CrCrCtD
Halobetasol Propionate—Methylprednisolone—Triamcinolone—hematologic cancer	0.00224	0.00788	CrCrCtD
Halobetasol Propionate—Betamethasone—Prednisone—hematologic cancer	0.00222	0.00782	CrCrCtD
Halobetasol Propionate—Rimexolone—Prednisone—hematologic cancer	0.00222	0.00782	CrCrCtD
Halobetasol Propionate—Dexamethasone—Prednisone—hematologic cancer	0.00222	0.00782	CrCrCtD
Halobetasol Propionate—Mometasone—Prednisolone—hematologic cancer	0.00222	0.00781	CrCrCtD
Halobetasol Propionate—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00222	0.00781	CrCrCtD
Halobetasol Propionate—Triamcinolone—Prednisolone—hematologic cancer	0.00222	0.00781	CrCrCtD
Halobetasol Propionate—Fluorometholone—Prednisolone—hematologic cancer	0.00222	0.00781	CrCrCtD
Halobetasol Propionate—Betamethasone—Prednisolone—hematologic cancer	0.00217	0.00763	CrCrCtD
Halobetasol Propionate—Dexamethasone—Prednisolone—hematologic cancer	0.00217	0.00763	CrCrCtD
Halobetasol Propionate—Rimexolone—Prednisolone—hematologic cancer	0.00217	0.00763	CrCrCtD
Halobetasol Propionate—Methylprednisolone—Prednisone—hematologic cancer	0.00212	0.00748	CrCrCtD
Halobetasol Propionate—Methylprednisolone—Prednisolone—hematologic cancer	0.00207	0.0073	CrCrCtD
Halobetasol Propionate—NR3C1—Signaling events mediated by HDAC Class II—RFXANK—hematologic cancer	0.000803	0.0406	CbGpPWpGaD
Halobetasol Propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CRY2—hematologic cancer	0.0004	0.0203	CbGpPWpGaD
Halobetasol Propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CRY1—hematologic cancer	0.0004	0.0203	CbGpPWpGaD
Halobetasol Propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PER2—hematologic cancer	0.0004	0.0203	CbGpPWpGaD
Halobetasol Propionate—SERPINA6—hematopoietic system—hematologic cancer	0.0004	0.204	CbGeAlD
Halobetasol Propionate—NR3C1—Transcription factor regulation in adipogenesis—CEBPA—hematologic cancer	0.000349	0.0176	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Transcription factor regulation in adipogenesis—CEBPD—hematologic cancer	0.000349	0.0176	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Signaling events mediated by HDAC Class II—HDAC11—hematologic cancer	0.000333	0.0169	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Signaling events mediated by HDAC Class II—GATA2—hematologic cancer	0.000308	0.0156	CbGpPWpGaD
Halobetasol Propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PER1—hematologic cancer	0.000303	0.0153	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Signaling events mediated by HDAC Class II—HDAC10—hematologic cancer	0.000297	0.015	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Circadian Clock—CRY1—hematologic cancer	0.000292	0.0147	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Circadian Clock—PER2—hematologic cancer	0.000292	0.0147	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Circadian Clock—CRY2—hematologic cancer	0.000292	0.0147	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Signaling events mediated by HDAC Class II—BCL6—hematologic cancer	0.000279	0.0141	CbGpPWpGaD
Halobetasol Propionate—SERPINA6—blood—hematologic cancer	0.000265	0.135	CbGeAlD
Halobetasol Propionate—NR3C1—Signaling events mediated by HDAC Class II—GATA1—hematologic cancer	0.000265	0.0134	CbGpPWpGaD
Halobetasol Propionate—SERPINA6—bone marrow—hematologic cancer	0.000256	0.131	CbGeAlD
Halobetasol Propionate—NR3C1—Nuclear Receptors—RARA—hematologic cancer	0.000242	0.0122	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of Androgen receptor activity—GATA2—hematologic cancer	0.000236	0.0119	CbGpPWpGaD
Halobetasol Propionate—SERPINA6—lung—hematologic cancer	0.000232	0.119	CbGeAlD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—PBX1—hematologic cancer	0.000228	0.0115	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Circadian Clock—PER1—hematologic cancer	0.000221	0.0112	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Endoderm Differentiation—DUSP5—hematologic cancer	0.000219	0.0111	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Signaling events mediated by HDAC Class II—TUBB2A—hematologic cancer	0.000218	0.011	CbGpPWpGaD
Halobetasol Propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—ARNTL—hematologic cancer	0.000216	0.0109	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—CBFB—hematologic cancer	0.000214	0.0108	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—MAF—hematologic cancer	0.000214	0.0108	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Signaling events mediated by HDAC Class II—NCOR2—hematologic cancer	0.000203	0.0103	CbGpPWpGaD
Halobetasol Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPA—hematologic cancer	0.0002	0.0101	CbGpPWpGaD
Halobetasol Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CEBPD—hematologic cancer	0.0002	0.0101	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—TLX3—hematologic cancer	0.000197	0.00994	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Signaling events mediated by HDAC Class II—SUMO1—hematologic cancer	0.000191	0.00968	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Nuclear Receptor transcription pathway—RARA—hematologic cancer	0.000191	0.00968	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CBFB—hematologic cancer	0.000191	0.00964	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—SPI1—hematologic cancer	0.000189	0.00955	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—GATA2—hematologic cancer	0.000189	0.00954	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Endoderm Differentiation—EOMES—hematologic cancer	0.000187	0.00943	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Signaling events mediated by HDAC Class II—HDAC9—hematologic cancer	0.000185	0.00938	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—TCF3—hematologic cancer	0.000182	0.0092	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Nuclear Receptor transcription pathway—NR0B2—hematologic cancer	0.000178	0.009	CbGpPWpGaD
Halobetasol Propionate—NR3C1—hematopoietic system—hematologic cancer	0.000175	0.0895	CbGeAlD
Halobetasol Propionate—NR3C1—Regulation of Androgen receptor activity—CEBPA—hematologic cancer	0.000173	0.00872	CbGpPWpGaD
Halobetasol Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—hematologic cancer	0.000163	0.00825	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Signaling events mediated by HDAC Class II—NUP214—hematologic cancer	0.000159	0.00806	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Circadian Clock—ARNTL—hematologic cancer	0.000157	0.00796	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—EBF1—hematologic cancer	0.000147	0.00741	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Endoderm Differentiation—LEF1—hematologic cancer	0.000144	0.00727	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Transcription factor regulation in adipogenesis—FOXO1—hematologic cancer	0.000143	0.00721	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—PBX1—hematologic cancer	0.000136	0.00689	CbGpPWpGaD
Halobetasol Propionate—NR3C1—gonad—hematologic cancer	0.000133	0.068	CbGeAlD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—hematologic cancer	0.000132	0.00668	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—SGK1—hematologic cancer	0.000131	0.00662	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of Androgen receptor activity—REL—hematologic cancer	0.000127	0.0064	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—ID3—hematologic cancer	0.000125	0.0063	CbGpPWpGaD
Halobetasol Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—hematologic cancer	0.000124	0.00626	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—hematologic cancer	0.000116	0.00588	CbGpPWpGaD
Halobetasol Propionate—NR3C1—blood—hematologic cancer	0.000116	0.0593	CbGeAlD
Halobetasol Propionate—NR3C1—Signaling events mediated by HDAC Class II—HSP90AA1—hematologic cancer	0.000116	0.00587	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—GATA2—hematologic cancer	0.000115	0.00581	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—hematologic cancer	0.000115	0.00581	CbGpPWpGaD
Halobetasol Propionate—NR3C1—bone marrow—hematologic cancer	0.000112	0.0574	CbGeAlD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—JUND—hematologic cancer	0.00011	0.00558	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—MYB—hematologic cancer	0.000108	0.00548	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—hematologic cancer	0.000108	0.00547	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Nuclear Receptors—AR—hematologic cancer	0.000108	0.00547	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—TCF3—hematologic cancer	0.000108	0.00545	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Endoderm Differentiation—DKK1—hematologic cancer	0.000105	0.00529	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—hematologic cancer	0.000104	0.00528	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Transcription factor regulation in adipogenesis—CREB1—hematologic cancer	0.000103	0.00523	CbGpPWpGaD
Halobetasol Propionate—NR3C1—lung—hematologic cancer	0.000102	0.052	CbGeAlD
Halobetasol Propionate—Difluprednate—NR3C1—hematologic cancer	0.000101	0.0616	CrCbGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—GATA2—hematologic cancer	9.94e-05	0.00503	CbGpPWpGaD
Halobetasol Propionate—Prednicarbate—NR3C1—hematologic cancer	9.76e-05	0.0597	CrCbGaD
Halobetasol Propionate—Clocortolone—NR3C1—hematologic cancer	9.76e-05	0.0597	CrCbGaD
Halobetasol Propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—hematologic cancer	9.66e-05	0.00488	CbGpPWpGaD
Halobetasol Propionate—NR3C1—testis—hematologic cancer	9.6e-05	0.049	CbGeAlD
Halobetasol Propionate—Diflorasone—NR3C1—hematologic cancer	9.24e-05	0.0565	CrCbGaD
Halobetasol Propionate—NR3C1—Endoderm Differentiation—PTHLH—hematologic cancer	9.11e-05	0.00461	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—RARA—hematologic cancer	9.05e-05	0.00458	CbGpPWpGaD
Halobetasol Propionate—Desoximetasone—NR3C1—hematologic cancer	9.01e-05	0.0551	CrCbGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—STAT5B—hematologic cancer	8.93e-05	0.00452	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of Androgen receptor activity—HSP90AA1—hematologic cancer	8.89e-05	0.00449	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—RET—hematologic cancer	8.78e-05	0.00444	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Nuclear Receptor transcription pathway—AR—hematologic cancer	8.55e-05	0.00432	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—CEBPD—hematologic cancer	8.42e-05	0.00426	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—CEBPA—hematologic cancer	8.42e-05	0.00426	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Generic Transcription Pathway—ZNF552—hematologic cancer	8.3e-05	0.0042	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Endoderm Differentiation—EZH2—hematologic cancer	8.29e-05	0.00419	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of Androgen receptor activity—AR—hematologic cancer	8.29e-05	0.00419	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—hematologic cancer	8.22e-05	0.00416	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—IL13—hematologic cancer	8.17e-05	0.00413	CbGpPWpGaD
Halobetasol Propionate—Flumethasone Pivalate—NR3C1—hematologic cancer	7.76e-05	0.0475	CrCbGaD
Halobetasol Propionate—NR3C1—Adipogenesis—NCOR2—hematologic cancer	7.6e-05	0.00384	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—hematologic cancer	7.45e-05	0.00376	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—hematologic cancer	7.43e-05	0.00376	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Nuclear Receptors—ESR1—hematologic cancer	7.43e-05	0.00376	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—GATA3—hematologic cancer	7.37e-05	0.00373	CbGpPWpGaD
Halobetasol Propionate—Amcinonide—NR3C1—hematologic cancer	7.09e-05	0.0434	CrCbGaD
Halobetasol Propionate—NR3C1—Regulation of Androgen receptor activity—FOXO1—hematologic cancer	7.06e-05	0.00357	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—hematologic cancer	7.04e-05	0.00356	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Circadian Clock—NCOR1—hematologic cancer	7.03e-05	0.00356	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Endoderm Differentiation—STAT1—hematologic cancer	7.02e-05	0.00355	CbGpPWpGaD
Halobetasol Propionate—NR3C1—lymph node—hematologic cancer	6.96e-05	0.0355	CbGeAlD
Halobetasol Propionate—Fluticasone furoate—NR3C1—hematologic cancer	6.96e-05	0.0426	CrCbGaD
Halobetasol Propionate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—hematologic cancer	6.92e-05	0.0035	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—hematologic cancer	6.81e-05	0.00344	CbGpPWpGaD
Halobetasol Propionate—Mometasone—NR3C1—hematologic cancer	6.75e-05	0.0413	CrCbGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—hematologic cancer	6.74e-05	0.00341	CbGpPWpGaD
Halobetasol Propionate—Rimexolone—NR3C1—hematologic cancer	6.67e-05	0.0408	CrCbGaD
Halobetasol Propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—hematologic cancer	6.65e-05	0.00336	CbGpPWpGaD
Halobetasol Propionate—Beclomethasone—NR3C1—hematologic cancer	6.29e-05	0.0385	CrCbGaD
Halobetasol Propionate—Fluocinonide—NR3C1—hematologic cancer	6.29e-05	0.0385	CrCbGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—HSP90AA1—hematologic cancer	6.27e-05	0.00317	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—RUNX3—hematologic cancer	6.19e-05	0.00313	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—STAT5B—hematologic cancer	6.18e-05	0.00312	CbGpPWpGaD
Halobetasol Propionate—Fluocinolone Acetonide—NR3C1—hematologic cancer	6.11e-05	0.0374	CrCbGaD
Halobetasol Propionate—Alclometasone—NR3C1—hematologic cancer	6.11e-05	0.0374	CrCbGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—STAT1—hematologic cancer	6.04e-05	0.00306	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—HDAC9—hematologic cancer	5.99e-05	0.00303	CbGpPWpGaD
Halobetasol Propionate—Flunisolide—NR3C1—hematologic cancer	5.95e-05	0.0364	CrCbGaD
Halobetasol Propionate—Clobetasol propionate—NR3C1—hematologic cancer	5.95e-05	0.0364	CrCbGaD
Halobetasol Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—hematologic cancer	5.94e-05	0.00301	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—FOXM1—hematologic cancer	5.93e-05	0.003	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—hematologic cancer	5.9e-05	0.00299	CbGpPWpGaD
Halobetasol Propionate—Paramethasone—NR3C1—hematologic cancer	5.88e-05	0.036	CrCbGaD
Halobetasol Propionate—NR3C1—Nuclear Receptor transcription pathway—ESR1—hematologic cancer	5.87e-05	0.00297	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of Androgen receptor activity—MAPK14—hematologic cancer	5.8e-05	0.00293	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—IL10—hematologic cancer	5.8e-05	0.00293	CbGpPWpGaD
Halobetasol Propionate—Fluorometholone—NR3C1—hematologic cancer	5.74e-05	0.0351	CrCbGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—CSF2—hematologic cancer	5.73e-05	0.0029	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—MYB—hematologic cancer	5.71e-05	0.00289	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—IL4—hematologic cancer	5.64e-05	0.00285	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Transcription factor regulation in adipogenesis—TNF—hematologic cancer	5.57e-05	0.00282	CbGpPWpGaD
Halobetasol Propionate—Methylprednisolone—NR3C1—hematologic cancer	5.55e-05	0.0339	CrCbGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—hematologic cancer	5.44e-05	0.00275	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—hematologic cancer	5.44e-05	0.00275	CbGpPWpGaD
Halobetasol Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—hematologic cancer	5.42e-05	0.00274	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—hematologic cancer	5.16e-05	0.00261	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—hematologic cancer	5.16e-05	0.00261	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—HLA-A—hematologic cancer	5.11e-05	0.00258	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—GATA3—hematologic cancer	5.1e-05	0.00258	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—CSF2—hematologic cancer	5.05e-05	0.00256	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—hematologic cancer	5.03e-05	0.00254	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of Androgen receptor activity—CREBBP—hematologic cancer	4.99e-05	0.00252	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—BAX—hematologic cancer	4.98e-05	0.00252	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Circadian Clock—CREB1—hematologic cancer	4.97e-05	0.00251	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—IL4—hematologic cancer	4.97e-05	0.00251	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—IL13—hematologic cancer	4.88e-05	0.00247	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Circadian Clock—CREBBP—hematologic cancer	4.84e-05	0.00245	CbGpPWpGaD
Halobetasol Propionate—Triamcinolone—NR3C1—hematologic cancer	4.68e-05	0.0286	CrCbGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—ESR1—hematologic cancer	4.56e-05	0.0023	CbGpPWpGaD
Halobetasol Propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—hematologic cancer	4.53e-05	0.00229	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Endoderm Differentiation—NOTCH1—hematologic cancer	4.51e-05	0.00228	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Transcription factor regulation in adipogenesis—IL6—hematologic cancer	4.5e-05	0.00227	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—GATA3—hematologic cancer	4.41e-05	0.00223	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—hematologic cancer	4.31e-05	0.00218	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of Androgen receptor activity—MDM2—hematologic cancer	4.24e-05	0.00214	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—STAT1—hematologic cancer	4.18e-05	0.00211	CbGpPWpGaD
Halobetasol Propionate—Fluticasone Propionate—NR3C1—hematologic cancer	4.18e-05	0.0256	CrCbGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—FOS—hematologic cancer	4.11e-05	0.00208	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—CREB1—hematologic cancer	4.1e-05	0.00207	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—hematologic cancer	4.09e-05	0.00207	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—hematologic cancer	4.07e-05	0.00206	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—hematologic cancer	4.05e-05	0.00205	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—CCL2—hematologic cancer	4.01e-05	0.00203	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—ZNF552—hematologic cancer	4e-05	0.00202	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—hematologic cancer	3.95e-05	0.002	CbGpPWpGaD
Halobetasol Propionate—Betamethasone—NR3C1—hematologic cancer	3.83e-05	0.0234	CrCbGaD
Halobetasol Propionate—NR3C1—Adipogenesis—STAT5A—hematologic cancer	3.76e-05	0.0019	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of Androgen receptor activity—JUN—hematologic cancer	3.68e-05	0.00186	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hematologic cancer	3.65e-05	0.00185	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—hematologic cancer	3.65e-05	0.00184	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—FOS—hematologic cancer	3.62e-05	0.00183	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—CREB1—hematologic cancer	3.61e-05	0.00183	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—hematologic cancer	3.55e-05	0.0018	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—NCOR1—hematologic cancer	3.53e-05	0.00179	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—hematologic cancer	3.52e-05	0.00178	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—CDKN2A—hematologic cancer	3.5e-05	0.00177	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—AR—hematologic cancer	3.49e-05	0.00177	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of Androgen receptor activity—MAPK8—hematologic cancer	3.48e-05	0.00176	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—FOXO1—hematologic cancer	3.44e-05	0.00174	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—IFNG—hematologic cancer	3.41e-05	0.00172	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of Androgen receptor activity—EP300—hematologic cancer	3.4e-05	0.00172	CbGpPWpGaD
Halobetasol Propionate—Fluticasone furoate—ABCB1—hematologic cancer	3.36e-05	0.0205	CrCbGaD
Halobetasol Propionate—NR3C1—Generic Transcription Pathway—RARA—hematologic cancer	3.31e-05	0.00167	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of Androgen receptor activity—SRC—hematologic cancer	3.3e-05	0.00167	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Circadian Clock—EP300—hematologic cancer	3.3e-05	0.00167	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—FAS—hematologic cancer	3.17e-05	0.0016	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—CDKN1B—hematologic cancer	3.1e-05	0.00157	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Generic Transcription Pathway—NR0B2—hematologic cancer	3.07e-05	0.00155	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—HES1—hematologic cancer	3.07e-05	0.00155	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—IL10—hematologic cancer	3.05e-05	0.00154	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—IL2—hematologic cancer	3.03e-05	0.00153	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—CASC3—hematologic cancer	3.03e-05	0.00153	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hematologic cancer	3e-05	0.00152	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—MDM2—hematologic cancer	2.99e-05	0.00151	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—CCND1—hematologic cancer	2.95e-05	0.00149	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—JUN—hematologic cancer	2.95e-05	0.00149	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—PTEN—hematologic cancer	2.85e-05	0.00144	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Generic Transcription Pathway—NCOR2—hematologic cancer	2.77e-05	0.0014	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—EP300—hematologic cancer	2.72e-05	0.00138	CbGpPWpGaD
Halobetasol Propionate—Methylprednisolone—ABCB1—hematologic cancer	2.68e-05	0.0164	CrCbGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—IL2—hematologic cancer	2.67e-05	0.00135	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	2.62e-05	0.00133	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—JUN—hematologic cancer	2.6e-05	0.00131	CbGpPWpGaD
Halobetasol Propionate—Dexamethasone—ABCG2—hematologic cancer	2.58e-05	0.0158	CrCbGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	2.54e-05	0.00129	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hematologic cancer	2.52e-05	0.00127	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—CREB1—hematologic cancer	2.5e-05	0.00126	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hematologic cancer	2.46e-05	0.00124	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—RB1—hematologic cancer	2.42e-05	0.00123	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	2.42e-05	0.00122	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Endoderm Differentiation—TGFB1—hematologic cancer	2.42e-05	0.00122	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—EP300—hematologic cancer	2.4e-05	0.00121	CbGpPWpGaD
Halobetasol Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	2.38e-05	0.0012	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—MYC—hematologic cancer	2.37e-05	0.0012	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—TGFB1—hematologic cancer	2.36e-05	0.0012	CbGpPWpGaD
Halobetasol Propionate—Dexamethasone—NR3C1—hematologic cancer	2.23e-05	0.0136	CrCbGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	2.16e-05	0.00109	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—hematologic cancer	2.15e-05	0.00109	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	2.11e-05	0.00107	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	2.11e-05	0.00107	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	2.1e-05	0.00106	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—RARS—hematologic cancer	1.95e-05	0.000987	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—TP53—hematologic cancer	1.95e-05	0.000984	CbGpPWpGaD
Halobetasol Propionate—Betamethasone—ABCB1—hematologic cancer	1.85e-05	0.0113	CrCbGaD
Halobetasol Propionate—NR3C1—Gene Expression—POLR3E—hematologic cancer	1.84e-05	0.000928	CbGpPWpGaD
Halobetasol Propionate—NR3C1—AP-1 transcription factor network—IL6—hematologic cancer	1.78e-05	0.000901	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Generic Transcription Pathway—PARP1—hematologic cancer	1.77e-05	0.000893	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—CDKN1A—hematologic cancer	1.74e-05	0.000881	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—hematologic cancer	1.71e-05	0.000867	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	1.6e-05	0.00081	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	1.6e-05	0.000808	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—TET2—hematologic cancer	1.59e-05	0.000805	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—RARA—hematologic cancer	1.59e-05	0.000805	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	1.57e-05	0.000794	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—RPLP1—hematologic cancer	1.56e-05	0.000789	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—STAT3—hematologic cancer	1.55e-05	0.000786	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	1.55e-05	0.000785	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—NR0B2—hematologic cancer	1.48e-05	0.000748	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	1.48e-05	0.000747	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	1.46e-05	0.000739	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	1.45e-05	0.000732	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—TGFB1—hematologic cancer	1.44e-05	0.000729	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	1.43e-05	0.000724	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—DNMT3A—hematologic cancer	1.41e-05	0.000714	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—ELL—hematologic cancer	1.39e-05	0.000703	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	1.36e-05	0.000688	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	1.36e-05	0.000686	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—TNF—hematologic cancer	1.35e-05	0.00068	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—NCOR2—hematologic cancer	1.34e-05	0.000675	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	1.29e-05	0.000653	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—AGO2—hematologic cancer	1.23e-05	0.000623	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—DNMT3B—hematologic cancer	1.21e-05	0.00061	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—H3F3B—hematologic cancer	1.21e-05	0.00061	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	1.16e-05	0.000588	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—RPS14—hematologic cancer	1.1e-05	0.000558	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—NUP98—hematologic cancer	1.09e-05	0.000549	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Adipogenesis—IL6—hematologic cancer	1.09e-05	0.000549	CbGpPWpGaD
Halobetasol Propionate—Dexamethasone—ABCB1—hematologic cancer	1.08e-05	0.00658	CrCbGaD
Halobetasol Propionate—NR3C1—Gene Expression—NUP214—hematologic cancer	1.05e-05	0.000529	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	1.01e-05	0.000513	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	9.8e-06	0.000496	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	9.64e-06	0.000488	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—HSPB1—hematologic cancer	9.64e-06	0.000488	CbGpPWpGaD
Halobetasol Propionate—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	9.38e-06	0.000474	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—SMC1A—hematologic cancer	9.23e-06	0.000467	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—H3F3A—hematologic cancer	9.05e-06	0.000458	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	8.89e-06	0.000449	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—EZH2—hematologic cancer	8.68e-06	0.000439	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—PARP1—hematologic cancer	8.5e-06	0.00043	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—HDAC2—hematologic cancer	8.2e-06	0.000415	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—AR—hematologic cancer	7.11e-06	0.000359	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—CDKN2B—hematologic cancer	6.55e-06	0.000331	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—NCOR1—hematologic cancer	6.21e-06	0.000314	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	5.27e-06	0.000267	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—MAPK14—hematologic cancer	4.98e-06	0.000252	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—ESR1—hematologic cancer	4.88e-06	0.000247	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—NOTCH1—hematologic cancer	4.72e-06	0.000239	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—CREBBP—hematologic cancer	4.28e-06	0.000216	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—MAPK3—hematologic cancer	2.61e-06	0.000132	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—MYC—hematologic cancer	2.54e-06	0.000128	CbGpPWpGaD
Halobetasol Propionate—NR3C1—Gene Expression—AKT1—hematologic cancer	1.76e-06	8.9e-05	CbGpPWpGaD
